PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

Overview of attention for article published in Frontiers in immunology, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 5 X users

patent: 1 patent

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 40,821 followers.

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report #lymphoma #lymsm https://t.co/IMDqJxQgqd

12 Jun 2021

Reply Repost Favourite

RT @CARTTherapy: PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBC…

12 Jun 2021

Reply Repost Favourite

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report https://t.co/9YFsxkWTIQ #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy @FrontIm

11 Jun 2021

Reply Repost Favourite

New article: PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report https://t.co/BRLBx7o48k #DLBCL #lymsm #hematology https://t.co/7KiZ9eM9OV

11 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.